Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial
Status:
Terminated
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The CHAT Pilot Trial is designed to compare rosuvastatin against placebo in patients with
suspected H1N1. The pilot study will assess the feasibility of our clinical protocols, and
study procedures.
Phase:
Phase 2
Details
Lead Sponsor:
Canadian Critical Care Trials Group
Collaborators:
Canadian Institutes of Health Research (CIHR) Public Health Agency of Canada (PHAC) The Physicians' Services Incorporated Foundation